In a study published in Nature, South Korean researchers led by Director Koh Gou Young of the Center for Vascular Research within the Institute for Basic Science (IBS) have uncovered a distinctive ...
ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional gut lymphatics and local inflammation linked to metabolic disease and ...
The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results